免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

FDA 510(k)

ManaFlexx 2(型号:MF002-RX,MF002-OTC)

K号: K231569 · 2023-11-03

申请人Manamed, Inc.
决定日期2023-11-03
产品代码NUH
咨询委员会NE 请注意,您提供的文本“NE”不足以进行翻译,因为它不是一个完整的句子或描述。请提供完整的医疗设备监管文本,以便我能够进行准确的翻译。
决定实质等同

器械摘要

ManaFlexx 2 (model: MF002-RX, MF002-OTC) is the device name listed in this FDA 510(k) record. The listed applicant is Manamed, Inc.. It received FDA 510(k) clearance on 2023-11-03 under 510(k) number K231569. The device is classified under product code NUH. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

常见问题

What is the ManaFlexx 2 (model: MF002-RX, MF002-OTC)?

ManaFlexx 2 (model: MF002-RX, MF002-OTC) is a medical device that received FDA 510(k) clearance on 2023-11-03. The listed applicant is Manamed, Inc.. The 510(k) number is K231569.

When did ManaFlexx 2 (model: MF002-RX, MF002-OTC) receive FDA 510(k) clearance?

ManaFlexx 2 (model: MF002-RX, MF002-OTC) received FDA 510(k) clearance on 2023-11-03, under 510(k) number K231569.

Who is the listed applicant for ManaFlexx 2 (model: MF002-RX, MF002-OTC)?

The FDA 510(k) record lists Manamed, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ManaFlexx 2 (model: MF002-RX, MF002-OTC)?

The FDA product code for ManaFlexx 2 (model: MF002-RX, MF002-OTC) is NUH.

相关临床试验

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

列明Manamed, Inc.为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

查看所有 7 个设备 →

相关器械(代码:NUH)

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系;请查阅链接的官方来源。

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息,请务必参考官方记录。

↑